Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients with cancer Jeito Capital co-leads oversubscribed EUR 50 million Series C financing with Brandon Capital CatalYm is developing a new class of anti-cancer immunotherapies, which have already demonstrated initial promising clinical results in advanced-stage solid tumor patients […]

Read More

SHANGHAI, China, Nov. 22, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the supplemental application for additional indications of adalimumab injection (project code: UBP1211, trade name: 君邁康®) for the treatment […]

Read More

VILNIUS, Lithuania, Nov. 21, 2022 (GLOBE NEWSWIRE) — With 12 years of market experience under its belt already, Locatory.com is not slowing down. The aviation marketplace for aircraft spare parts and repair capabilities and a family member of Avia Solutions Group, leaders in end-to-end capacity solutions for passenger and cargo airlines worldwide, is talking about […]

Read More